Cancer Antigen 19‐9 (CA 19–9) is primarily used for pancreatic and gastrointestinal cancers but is elevated in some OC cases, particularly mucinous tumors, aiding differentiation of benign from malignant tumors when CA‐125 is normal [48, 49]. The gene discussed is MUC16; the disease is cancer.